Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases
about
Structure of complement fragment C3b-factor H and implications for host protection by complement regulatorsStructure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variationsInteraction of Decay-Accelerating Factor with Coxsackievirus B3Interaction of Decay-Accelerating Factor with Echovirus 7The Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus SurfaceEquilibrium and kinetics of Sin Nombre hantavirus binding at DAF/CD55 functionalized bead surfaces.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challengesNeurosteroids reduce inflammation after TBI through CD55 induction.Autoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and Neisserial sepsis: C4 nephritic factor revisited.Dissection of functional sites in herpesvirus saimiri complement control protein homolog.Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.How novel structures inform understanding of complement function.Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.DAF in diabetic patients is subject to glycation/inactivation at its active site residues.
P2860
Q24646723-9961B92B-7E3B-4F6A-95CB-CBC26BB3A556Q24648540-5E03C736-3FBD-4524-A7B5-1316B528CFE1Q27647885-64FC8FD3-083C-4BD1-9D3B-5DD7A065D141Q27664791-5E0587DA-C654-4014-B2B9-75CCD75BC893Q27673022-47ACD55D-64D6-4235-B5C7-92D59773218BQ30441117-F2C31069-5AD5-4D6B-B012-6A050C077AB0Q34297628-AD56BF2B-CF4D-40E6-B79C-FF4E78F3D704Q34682946-1FC37212-5B30-43ED-B878-44E1A43C9A86Q36409764-451CF15B-FBB2-4E1C-8A91-0CA6EFEF6E97Q36506856-689F3094-7BAB-492A-A2B3-4FB8D12F632BQ36906411-55D21C87-7C8B-45BC-8957-422475641554Q37362130-D01AADDD-D776-4932-9480-0B2C2FFAB7DFQ38624669-DF25AB3B-49ED-4AE4-9A18-F3B236D6A08BQ38671434-F0E6DC96-9862-489F-B92A-74515EAE8731Q47832785-8D536724-8E08-4E1C-952A-A846AAC1DCC0
P2860
Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2007
@uk
name
Structure-based Mapping of DAF ...... te the Decay of C3 Convertases
@en
Structure-based Mapping of DAF ...... te the Decay of C3 Convertases
@nl
type
label
Structure-based Mapping of DAF ...... te the Decay of C3 Convertases
@en
Structure-based Mapping of DAF ...... te the Decay of C3 Convertases
@nl
prefLabel
Structure-based Mapping of DAF ...... te the Decay of C3 Convertases
@en
Structure-based Mapping of DAF ...... te the Decay of C3 Convertases
@nl
P2093
P2860
P356
P1476
Structure-based mapping of DAF ...... te the decay of C3 convertases
@en
P2093
Dennis E Hourcade
Lisa Kuttner-Kondo
Lynne Mitchell
M Edward Medof
Nasima Muqim
Paul N Barlow
Vernon E Anderson
P2860
P304
18552-18562
P356
10.1074/JBC.M611650200
P407
P577
2007-03-29T00:00:00Z